News | February 13, 2007

Patients Driving With an ICD? Physicians, Take Note

Feb. 14, 2007 — The American Heart Association and the Heart Rhythm Society have issued expanded driving precautions pertaining to people with an implantable cardiac defibrillator. The guidelines are an update to previous recommendations.

The two organizations published an advisory in that largely focused on individuals who had been given an ICD for secondary prevention of life-threatening heart-rhythm disturbances Since the release of that document, newer findings from a number of studies have shown the benefit of ICDs for preventing a first cardiac event in people who are at high risk. Also, in 2005, Medicare began to cover ICDs for primary prevention.

AHA and HRS now believe the time is right to develop driving restrictions specifically for primary prevention ICD patients.

Recommendations include:

1. Patients given an ICD for primary prevention should not drive an automobile for at least 1 week after the procedure to allow for postoperative recovery.

2. If the patient gets an ICD shock to correct a rhythm irregularity, then the previously set restriction for secondary prevention should apply -- that is, no driving for six months after the event.

3. Patients given an ICD for primary prevention should be informed that impaired consciousness is now a possible future occurrence.

4. These restrictions apply to private driving, not commercial driving. Federal law prohibits all patients with an ICD (for primary or secondary prevention) from being certified for commercial driving.

Full details are published in the Feb. 7 issue of AHA’s journal, “Circulation.”


Related Content

News | Implantable Cardioverter Defibrillator (ICD)

Sept. 2, 2024 – Medtronic recently shared long-term results from the global Extravascular Implantable Cardioverter ...

Home September 05, 2024
Home
News | Implantable Cardioverter Defibrillator (ICD)

February 12, 2024 — BIOTRONIK, a leader in implantable medical device technology, announced today they will solely ...

Home February 12, 2024
Home
News | Implantable Cardioverter Defibrillator (ICD)

October 23, 2023 — Medtronic plc, a global leader in healthcare technology, has received U.S. Food and Drug ...

Home October 23, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 28, 2023 — Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial ...

Home August 28, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 28, 2023 — Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and ...

Home August 28, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Medtronic ICDs and CRT-Ds ...

Home July 18, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

March 7, 2023 — Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no ...

Home March 07, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

February 17, 2023 — Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan ...

Home February 17, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...

Home August 29, 2022
Home
Subscribe Now